Day: March 25, 2024

Live Demonstration at OFC 2024 Based on Ultrareliable DLX™ TechnologyCoherent Datacenter Lightwave Cross-Connect (DLX)Coherent will hold a first-of-its-kind demo at OFC 2024 of a 300×300-port optical circuit switch based on ultrareliable DLX technology, revolutionizing data center networks for AI deployments.PITTSBURGH, March 25, 2024 (GLOBE NEWSWIRE) — Coherent Corp. (NYSE: COHR), a global leader in optical communications materials, components, and subsystems, announced today the introduction of a new optical circuit switch (OCS) based on the company’s field-proven and ultrareliable Datacenter Lightwave Cross-Connect (DLX™). Deploying an OCS-based architecture enables operators of artificial intelligence (AI) clusters to dramatically reduce the number of electrical switches required in data center...

VANCOUVER, British Columbia and LAS VEGAS, March 25, 2024 (GLOBE NEWSWIRE) — Hydreight Technologies Inc. (“Hydreight” or the “Company”) (TSXV:NURS)(OTCQB:HYDTF)(FSE:S06) a mobile clinical network and medical platform which enables flexible, at-home medical services across 50 states in the United States, is pleased to announce that it has partnered with American Frontline Nurses, a leading advocacy organization that offers programs that improve health outcomes for vulnerable patient populations by providing them with education and resources. American Frontline Nurses provides comprehensive education and resources to nurses, patients, and their families, enabling them to receive safe, equitable, and personalized care. American Frontline Nurses has a network of over 26,000 nurses across the United States and has helped over 8,000...

TORONTO, March 25, 2024 (GLOBE NEWSWIRE) — Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO) announced today that it received a decision from the Nasdaq Hearings Panel (the “Nasdaq Panel”) granting its request for continued listing on the Nasdaq Capital Market, subject to the Company demonstrating compliance with Nasdaq Listing Rule 5550(b)(1) or any of the alternative requirements under Nasdaq Listing Rule 5550(b) on or before May 28, 2024, and certain other conditions (the “Panel Decision”). On May 31, 2023, Nasdaq Listing Qualifications staff (“Nasdaq Staff”) issued the Company a deficiency notice citing that the stockholders’ equity as reported in the Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2023, was below the minimum $2,500,000 required for continued listing under Nasdaq Listing...

NEW YORK, March 25, 2024 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome, schizophrenia and other central nervous system (CNS) diseases, today announced that it will present at the 23rd Annual Needham Virtual Healthcare Conference, April 8 – 11, 2024. Christopher U Missling, PhD, President & Chief Executive Officer will present the Company scheduled at 8:45 AM (ET) on Monday, April 8th, 2024. A live audio webcast will be accessible through the Investors section of the Company’s website at www.anavex.com. An archived edition of the session will be available later that...

WALTHAM, Mass., March 25, 2024 (GLOBE NEWSWIRE) — OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professional (HCPs) and patients, will hold a conference call on Thursday, March 28, 2024, at 8:30 a.m. Eastern Time to discuss the preliminary, unaudited results for the fourth quarter. OptimizeRx management will host the call, followed by a question-and-answer period. Details for the conference call can be found below:Date: Thursday, March 28, 2024Time: 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time)Toll Free: 1-877-423-9813International: 1-201-689-8573Conference ID: 13745113Call Me Link: https://callme.viavid.com/viavid/?callme=true&passcode=13742267&h=true&info=company-email&r=true&B=6Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1661440&tp_key=c3193dc8d8Please...

Expands Focus on Sports & Entertainment in the United States and Globally SEOUL, South Korea, March 25, 2024 (GLOBE NEWSWIRE) — Captivision Inc. (NASDAQ: CAPT) today announced that Gary R. Garrabrant has been appointed Chairman and Chief Executive Officer of the company, effective immediately. Based in the U.S., Mr. Garrabrant will lead the firm’s strategic direction, including potential expansion in new geographies and promising sectors, chief among them sports and entertainment. Based in Seoul, company founder and former CEO Dr. Ho Joon Lee will lead Captivision’s innovation team globally as Chief Technology Officer and will continue to serve on the company’s Board of Directors. “I am thrilled and privileged to lead Captivision as Chairman and CEO as we capitalize on new growth opportunities globally,” said Mr. Garrabrant....

John CoxJohn Cox, President and CEO of Dyne Therapeutics– John Cox, Industry Leader with Global Experience in Rare Disease Commercialization, Joins Dyne as President and CEO – WALTHAM, Mass., March 25, 2024 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced the appointment of John Cox as president, chief executive officer (CEO) and a member of the Board of Directors, effective immediately. He succeeds Joshua Brumm, who has chosen to step down from these roles to pursue a career in healthcare investing. Mr. Brumm will serve as an advisor to Dyne to help ensure a seamless transition. “I’m thrilled to join Dyne. I was drawn to the recent...

Standard Farms Dubbed Best Vape Cartridge in Massachusetts PHOENIX, March 25, 2024 (GLOBE NEWSWIRE) — TILT Holdings Inc. (“TILT” or the “Company”) (Cboe: TILT) (OTCQB: TLLTF), a global provider of cannabis business solutions including inhalation technologies, cultivation, manufacturing, processing, brand development and retail, announced today that its subsidiary Standard Farms won first place for best vape cartridge in the 2024 NECANN Cup with the Mimosa Liquid Live Rosin “All-in-One” Vape using the Jupiter/CCELL Voca Pro hardware. “Being awarded the best vape product at one of the nation’s leading cannabis competitions with our sought-after Mimosa live rosin strain helps solidify TILT’s position as an industry leader in product and hardware innovation,” said Tim Conder, Chief Executive Officer of TILT. “Our team deserves recognition...

– The independent data monitoring committee (IDMC) recommended the continuation of VIRAGE, the Phase 2b clinical trial of VCN-01 in combination with chemotherapy for metastatic Pancreatic Ductal Adenocarcinoma (PDAC), with no safety concerns raised – – VIRAGE remains on track to complete enrollment in the first half of 2024- – As of December 31, 2023, Theriva Biologics reports $23.2 million in cash, which is expected to provide runway into the first quarter of 2025 – – Conference call and webcast to be held on Monday, March 25 at 8:30 a.m. ET – ROCKVILLE, Md., March 25, 2024 (GLOBE NEWSWIRE) — Theriva™ Biologics (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today reported financial...